1834 Investment Advisors Co. Boosts Stock Position in Bath & Body Works, Inc. (NYSE:BBWI)

1834 Investment Advisors Co. lifted its position in Bath & Body Works, Inc. (NYSE:BBWI) by 5.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,957 shares of the company’s stock after purchasing an additional 830 shares during the quarter. 1834 Investment Advisors Co.’s holdings in Bath & Body Works were worth $619,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Envestnet Asset Management Inc. raised its holdings in shares of Bath & Body Works by 5.7% during the second quarter. Envestnet Asset Management Inc. now owns 140,300 shares of the company’s stock worth $5,479,000 after purchasing an additional 7,611 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Bath & Body Works by 7.1% during the second quarter. Dimensional Fund Advisors LP now owns 1,303,487 shares of the company’s stock worth $50,901,000 after acquiring an additional 86,204 shares during the period. ProShare Advisors LLC lifted its holdings in Bath & Body Works by 6.5% in the second quarter. ProShare Advisors LLC now owns 30,533 shares of the company’s stock valued at $1,192,000 after acquiring an additional 1,855 shares during the period. Public Sector Pension Investment Board boosted its position in Bath & Body Works by 43.1% in the 2nd quarter. Public Sector Pension Investment Board now owns 9,874 shares of the company’s stock worth $386,000 after purchasing an additional 2,976 shares in the last quarter. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its stake in shares of Bath & Body Works by 59.8% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 40,920 shares of the company’s stock worth $1,598,000 after purchasing an additional 15,306 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Stock Down 0.8 %

NYSE:BBWI opened at $36.98 on Friday. Bath & Body Works, Inc. has a 52 week low of $26.20 and a 52 week high of $52.99. The stock’s fifty day moving average is $36.86 and its two-hundred day moving average is $33.64. The company has a market capitalization of $8.01 billion, a P/E ratio of 9.02, a P/E/G ratio of 1.01 and a beta of 1.82.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. During the same period last year, the business earned $0.48 earnings per share. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. Sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 22nd were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.16%. The ex-dividend date of this dividend was Friday, November 22nd. Bath & Body Works’s payout ratio is currently 19.51%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on BBWI shares. TD Cowen lifted their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a report on Thursday, December 12th. Argus restated a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $42.00 to $48.00 in a research note on Friday, January 10th. Finally, Barclays increased their target price on Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a report on Tuesday, November 26th. One analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $43.19.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.